Threatened Limb Loss Research Articles

Surgical Deep Vein Arterialization: Adding to the Armamentarium of Complex Limb Salvage

Patients with severe peripheral arterial disease with limited or nonexistent arterial runoff, the so-called "desert foot", challenge efforts at limb preservation. Deep vein arterialization (DVA) involves incorporating a venous target as an outflow to achieve revascularization in these complex patients. We report outcomes in an initial series of patients undergoing DVA as a component of surgical bypass. Over a 2-year period, 10 patients underwent bypass incorporating DVA due to severely disadvantaged runoff using a heparin-bonded expanded polytetrafluoroethylene conduit. Indications for surgery included tissue loss (8) or ischemic rest pain (2) in patients who had failed endovascular (3) or surgical (7) revascularization. Inflow arteries for bypass ranged from external iliac to below knee popliteal. Outflow anastomoses incorporated a common ostium arteriovenous fistula between anterior tibial (5), posterior tibial (2), peroneal (1) or plantaris pedis (2) arteries, and corresponding tibial veins. Prior to anastomotic completion, tibial vein valves were lysed to allow venous arterialization by a way of retrograde flow. Postoperative medical regimen included dual antiplatelet (2), antiplatelet plus anticoagulation (7), or anticoagulation alone (1). Primary patency was maintained in 7 of 10 grafts (average: 4.1 months, range: 1-18 months). Limb salvage was achieved in 8 of 10 patients (average: 6 months, range: 1-18 months). Two below knee amputations were performed after graft occlusion due to extensive tissue loss and infection, whereas 1 patient maintained limb salvage despite graft occlusion after successful wound healing. This initial experience describes surgical DVA using a prosthetic conduit in conjunction with an arteriovenous fistula at the distal anastomosis in patients with threatened limb loss and severely disadvantaged tibial runoff. Although evidence for long-term efficacy is uncertain, preliminary outcomes warrant further investigation as this technique may allow for surgical revascularization resulting in limb preservation for patients with no other alternative than amputation.

Surgical Deep Vein Arterialization: Adding To The Armamentarium Of Complex Limb Salvage

INTRODUCTION AND OBJECTIVES Patients with severe peripheral arterial disease with limited or non-existent arterial runoff, the so-called “desert foot”, challenge efforts at limb preservation. Deep vein arterialization (DVA) involves incorporating a venous target as outflow to achieve revascularization in these complex patients. We report outcomes in an initial series of patients undergoing DVA as a component of surgical bypass. METHODS Over a 2-year period, 10 patients underwent bypass incorporating DVA due to severely disadvantaged runoff using a heparin-bonded ePTFE conduit. Indications for surgery included tissue loss (8) or ischemic rest pain (2) in patients who had failed prior endovascular (3) or surgical (7) revascularization. Inflow arteries for bypass ranged from external iliac to below knee popliteal. Outflow anastomoses incorporated a common ostium AV fistula between anterior tibial (5), posterior tibial (2), peroneal (1) or plantaris pedis (2) arteries and corresponding tibial veins. Prior to anastomotic completion, tibial vein valves were lysed to allow venous arterialization through retrograde flow. Postoperative medical regimen included dual antiplatelet (2), antiplatelet plus anticoagulation (7), or anticoagulation alone (1). RESULTS Primary patency was maintained in 7 of 10 grafts (average of 4.1 months, range 1-18 months). Limb salvage was achieved in 8 of 10 patients (average of 6 months, range 1-18 months). 2 below knee amputations were performed after graft occlusion due to extensive tissue loss and infection, while 1 patient maintained limb salvage despite graft occlusion after successful wound healing. CONCLUSIONS This initial experience describes surgical DVA using a prosthetic conduit in conjunction with an AV fistula at the distal anastomosis in patients with threatened limb loss and severely disadvantaged tibial runoff. Although evidence for long-term efficacy is uncertain, further investigation is warranted as this technique may allow for surgical bypass resulting in limb preservation for patients with no other alternative than amputation. Patients with severe peripheral arterial disease with limited or non-existent arterial runoff, the so-called “desert foot”, challenge efforts at limb preservation. Deep vein arterialization (DVA) involves incorporating a venous target as outflow to achieve revascularization in these complex patients. We report outcomes in an initial series of patients undergoing DVA as a component of surgical bypass. Over a 2-year period, 10 patients underwent bypass incorporating DVA due to severely disadvantaged runoff using a heparin-bonded ePTFE conduit. Indications for surgery included tissue loss (8) or ischemic rest pain (2) in patients who had failed prior endovascular (3) or surgical (7) revascularization. Inflow arteries for bypass ranged from external iliac to below knee popliteal. Outflow anastomoses incorporated a common ostium AV fistula between anterior tibial (5), posterior tibial (2), peroneal (1) or plantaris pedis (2) arteries and corresponding tibial veins. Prior to anastomotic completion, tibial vein valves were lysed to allow venous arterialization through retrograde flow. Postoperative medical regimen included dual antiplatelet (2), antiplatelet plus anticoagulation (7), or anticoagulation alone (1). Primary patency was maintained in 7 of 10 grafts (average of 4.1 months, range 1-18 months). Limb salvage was achieved in 8 of 10 patients (average of 6 months, range 1-18 months). 2 below knee amputations were performed after graft occlusion due to extensive tissue loss and infection, while 1 patient maintained limb salvage despite graft occlusion after successful wound healing. This initial experience describes surgical DVA using a prosthetic conduit in conjunction with an AV fistula at the distal anastomosis in patients with threatened limb loss and severely disadvantaged tibial runoff. Although evidence for long-term efficacy is uncertain, further investigation is warranted as this technique may allow for surgical bypass resulting in limb preservation for patients with no other alternative than amputation.

Distal vein patch with an arteriovenous fistula: A viable option for the patient without autogenous conduit and severe distal occlusive disease

The addition of a distal arteriovenous fistula (DAVF) to improve patency in lower extremity bypass is well described. This report describes a technique of using a distal AVF to enhance a distal vein patch (DVP) in patients without adequate autogenous conduit and who have concomitant severely disadvantaged arterial runoff. A retrospective review from May 2002 to May 2007 analyzed 270 tibial bypasses. DVP-AVF was the conduit in 30 bypass grafts. Patient demographics included 16 men, 14 women, diabetes mellitus (67%), and chronic renal failure (20%). All patients had limb-threatening ischemia manifest as rest pain or tissue loss, with 20 patients referred after failed prior revascularization: 11 failed bypasses, and nine failed endovascular interventions. In each case, the only outflow artery available was an isolated tibial segment or a diseased pedal vessel not ordinarily deemed suitable for bypass. At surgery, a common ostium AVF was created between the outflow tibial artery and corresponding tibial vein before DVP construction. Follow-up was 1 to 24 months, with graft function evaluated by pulse examination and duplex surveillance. Primary patency and limb salvage +/- SE were determined by life-table analysis using Rutherford criteria. The proximal anastomosis originated from the external iliac (23%), common femoral artery (43%), and superficial femoral artery (33%). Outflow arteries included the anterior tibial (40%), posterior tibial (30%), and peroneal (30%). Venous hypertension in the bypassed limb was noted, but not considered problematic in any patient. Perioperative graft failure occurred in one patient. Six graft failures led to six major amputations (1 above knee; 5 below knee). One patent graft was excised due to infection. Primary patency at 6, 12, 18, and 24 months was 78.3% +/- 6.8%, 78.3% +/- 10.5%, 62.6% +/- 11.1%, and 62.6% +/- 15.6%; limb salvage was 78.7% +/- 6.7%, 78.7% +/- 10.1%, 78.7% +/- 10.1%, and 57.7% +/- 12.5%. This early experience describes a modification of the DVP technique in patients with threatened limb loss and severely disadvantaged tibial runoff. The addition of an AVF may reduce outflow resistance, thereby contributing to higher flow rates and improved graft patency. Further investigation is warranted because the DVP-AVF technique may result in acceptable graft patency and limb salvage for patients with no other alternative than amputation.

The Role of Pre and Postprocedural Color Duplex Ultrasound for the Treatment of Lower Limb Ischemia by Subintimal Angioplasty

Introduction Subintimal angioplasty (SIA) is the endovascular recanalization of vessels in the subintimal plane and most often is used to treat long-segment occlusions involving the femoropopliteal segment. This study demonstrates the value of pre- and postprocedural color duplex ultrasound (CDU) imaging. Methods Forty-three subintimal angioplasty procedures were performed to treat lower-extremity arterial occlusions. CDU was used as the definitive imaging modality in all cases. There were 26 women and 17 men, with a mean age of 76 years. Sixteen patients had anklebrachial index < 0.45. Most patients had significant medical comorbidities, placing them at high risk for arterial bypass procedures. Results In all patients, the extent of the occlusion was accurately diagnosed with CDU before intervention. SIA was technically successful in 42 of 43 patients (98%). The postprocedure CDU follow-up (1–2 months) demonstrated 10 patients had reoccluded (24%). Our primary patency rate was 42% at 30 months. Conclusion SIA can be an effective method of treatment in aged, high-risk patients with lower-extremity ischemia and threatened limb loss. CDU accurately locates the site of and measures the length of arterial occlusions in such patients, allowing the interventionalist to plan the site of arterial puncture and to prognosticate the likely success. CDU obviates the need for diagnostic angiography and remains the modality of choice for surveillance after SIA intervention.

Morbidity of adjuvant brachytherapy in soft tissue sarcoma of the extremity and superficial trunk

Purpose: We have previously shown that adjuvant brachytherapy (BRT) improves local control in soft tissue sarcoma (STS) of the extremity and superficial trunk. A detailed assessment of the morbidity of this approach has not been examined. The purpose of this study was to evaluate the toxicity associated with adjuvant BRT in terms of wound complications, bone fracture, and peripheral nerve damage. Methods and Materials: Between July 1982 and June 1992, 164 adult patients with STS of the extremity or superficial trunk were randomized intraoperatively to receive or not to receive BRT after complete resection. BRT was delivered with 192Ir to a total dose of 42–45 Gy. The BRT and no-BRT arms were balanced with regard to age, sex, presentation (primary vs. recurrent), site, grade, size, and depth. Morbidity was assessed in terms of significant wound complication, bone fracture, and peripheral nerve damage (grade ≥ 3). The significant wound complications were defined as those wound problems requiring operative revision for coverage or threatened limb loss, persistent seroma requiring repeated aspirations and/or drainage, wound separation > 2 cm, hematoma > 25 ml, and/or purulent wound discharge. The median follow-up was 100 months. Results: The significant wound complication rate was 24% in the BRT group and 14% in the no-BRT group, ( p = 0.13). The rate of wound reoperation, however, was significantly higher in the BRT arm (10% vs. 0%; p = 0.006). Examination of other covariables that may have contributed to wound reoperation revealed the width of the excised skin (WES) to be a significant factor [1% (WES ≤ 4 cm) vs. 10% (WES > 4 cm), p = 0.02]. Bone fracture only occurred in patients receiving BRT (n = 3, 4%), although this was not statistically significant ( p = 0.2). The rate of peripheral nerve damage, however, was similar in both arms (7% vs. 7%). Conclusion: The overall morbidity associated with adjuvant BRT was not significantly higher than that with surgery alone. However, BRT and WES > 4 cm were associated with significantly higher wound reoperation rate. This has significant implications for strategies designed to maximize wound coverage in patients who receive BRT.

Arterial reconstruction of vessels in the foot and ankle.

This study demonstrated that arterial reconstruction of vessels of the foot and ankle can preserve the majority of ischemic extremities with extensive tibial and peroneal occlusive disease and patent pedal arteries. There are successful reports of bypass procedures to the ankle and foot, but despite this, these procedures have not gained widespread acceptance among surgeons performing infra-inguinal revascularization. Primary amputation is often offered for such patients. For this reason, the authors have reviewed their experience with bypasses to the foot and ankle. A retrospective review was done of 75 arterial bypasses (5 bilateral), done since 1985, to the ankle and foot in 70 patients (38 males and 32 females). Fifty-four (77%) of the patients were diabetic. The age ranged from 55 to 95 years. Twenty-six (37%) were older than 80 years. The patients were selected for operative intervention because of severe tibioperoneal occlusive disease with ischemic rest pain or gangrene of the foot. Digital subtraction arteriography facilitated visualization of distal vessels. Operative principles included regional anesthesia, autogenous graft material, short bypass, non-traumatic vessel occlusion, selective operative arteriography, tension free ankle and foot skin closure, and concomitant conservative debridement of infected devitalized tissue. Incomplete pedal arch did not influence decision for operation. Indications for operation were: gangrene, 42 (56%); non-healing ulcer, 21 (28%); and rest pain, 12 (16%). Graft material was in situ greater saphenous vein, 40 (53%); translocated greater saphenous vein, 19 (25%); reversed greater saphenous vein, 11 (15%); and arm vein, lesser saphenous vein or vein patch, 5 (7%). Donor artery was popliteal, 30 (41%); common femoral, 26 (35%); and superficial femoral, 17 (23%). Recipient vessel was dorsalis pedis, 43 (57%); posterior tibial, 18 (24%); distal anterior tibial, 9 (12%); and distal peroneal, plantar or tibial endarterectomy, 5 (7%). There were four (5.7%) deaths and three (4.2%) graft failures within 30 days. Early graft failure led to transmetatarsal amputation (1), below knee amputation (1), and conversion of graft to femoral (1), popliteal bypass graft with limb salvage (1). In one patient, significant tissue necrosis with infection necessitated a below knee amputation within 30 days, despite a patent graft. Long-term follow-up revealed 10 graft failures, 4 major amputations, 3 graft revisions, and 15 deaths. Cumulative primary and secondary patency was 79.0% and 81.6% at 36 months. Limb salvage was 87.5% at 36 months. These results support an aggressive approach to limb salvage in patients with threatened limb loss, unreconstructable tibio-peroneal occlusive disease, and patent pedal arteries. Bypasses to the ankle and foot will maintain a functional extremity in the majority of these patients.

Cardiosynchronous limb compression: effects on noninvasive vascular tests and clinical course of the ischemic limb.

Some patients with chronic arterial obstruction of the limbs may still suffer the consequences of advanced tissue ischemia, including ulceration and rest pain, and face threatened limb loss in spite of available surgical, pharmacologic, and other treatments. Additional therapeutic modalities were thus sought to accomplish limb salvage. A literature review indicated that most reports on R-wave-triggered circumferential limb compression (cardiosynchronous limb compression [CSC]) demonstrate its ability to augment limb arterial blood flow and improve ischemic limbs. To determine the device's efficacy and safety, and possibly confirm earlier positive reports, a systematic study was undertaken, using older, as well as newer, more electronically reliable CSC devices. The present study was designed to determine the following: 1. objectively, by noninvasive vascular tests, changes in limb blood flow, if any, by CSC; 2. clinical effects of CSC, if any, on the ischemic limb; 3. duration of CSC-induced limb improvements, if any; 4. side effects or safety of CSC. The study demonstrated that CSC treatments: 1. caused increased limb blood flow as determined by increased ankle/arm indices and hallux photoplethysmograph waveform amplitudes during treatments; 2. led, in most cases, to improvement in or resolution of the presenting ischemic problem (eg, ulcer, cellulitis, rest pain); 3. induced limb improvements that persist for up to seven years 4. caused no adverse side effects.

The value of percutaneous transluminal angioplasty of the profunda femoris artery in threatened limb loss and intermittent claudication

Percutaneous transluminal angioplasty (PTA) has been performed on 29 profunda femoris artery stenoses in 26 limbs of 25 patients. Seventy per cent of the 27 atheromatous stenoses involved the origin or proximal 4 cm of the profunda. One patient had two strictures of a common femoral-profunda femoris vein graft. All had total superficial femoral or femoropopliteal occlusion (median length 29.5 cm, range 4-47 cm). The 13 patients presenting with threatened limb loss were significantly older than the remainder, who had disabling intermittent claudication (P = 0.03), and had twice the incidence of diabetes mellitus. They also had significantly fewer calf vessels patent compared with the claudicants (P = 0.008). The approaches used for profunda PTA included ipsilateral antegrade common femoral (19), ipsilateral retrograde profunda (3), cross-over technique (2), antegrade profunda (1) and brachial cutdown (1). Profunda PTA was technically successful at 26 sites (89.7%), partially successful at one, and failed at two. Concomitant PTA was successful at eight of 10 sites in eight patients. Complications requiring surgery occurred in two (7.7%). The median follow up was 17.5 months (range 1-62 months). Of the 12 limb salvage patients who underwent a technically successful profunda PTA, six required no further intervention, three subsequently underwent bypass grafting and three had an inevitable amputation, the level of amputation having been lowered in one of the patients. Nine claudicants improved symptomatically after technically successful profunda PTA; three underwent an operative procedure. Eight (61.5%) of the limb salvage group have now died, compared with two (15.4%) of the claudicants. Profunda femoris PTA is an effective alternative to profundaplasty in patients with femoropopliteal occlusive disease and may obviate the need for bypass surgery or amputation.

The complication rate of percutaneous peripheral balloon angioplasty

One thousand six hundred and forty-two vessel segments (46% iliac, 54% femoro-distal) in 1141 patients have undergone percutaneous peripheral balloon dilatation at the Northern General Hospital, Sheffield over a 9 year period. Forty-two significant complications were encountered in all; 28 of these were occlusive and half of these were treated by angioplasty itself, either by thrombolysis or catheter suction. There was one case of distal ischaemia attributed to cholesterol embolisation which led to death (Gaines et al., 1988). There were two cases of perforation and haematoma requiring surgery, one retroperitoneal haemorrhage and one false aneurysm. One diabetic patient developed septicaemia following successful PTA for an ischaemic foot and died. One case each of bowel ischaemia, cerebrovascular accident and myocardial infarction occurred within 24 h of the angioplasty procedure, but there was no clear causal relationship. Arterial wall dissection or perforation per se was not considered a complication unless it progressed to haemorrhage or vessel occlusion. There were three cases of femoral nerve damage causing sensory loss in the thigh, two of which were permanent. Four hundred and thirty-five procedures were performed in patients with rest ischaemia. Of these, 2.8% developed complications requiring surgery, but only 0.9% required reconstructive bypass surgery. For intermittent claudication 1207 procedures were performed, 0.7% of these developed complications requiring surgery but only 0.5% required reconstructive surgery. These results justify the use of angioplasty in the treatment of intermittent claudication and in poor risk patients with threatened limb loss.

A comparison of diabetics and nondiabetics with threatened limb loss

One hundred seventeen patients with threatened limb loss were evaluated. Seventy-three of these patients underwent vascular reconstruction. Diabetics had a significantly higher incidence of ischemic ulceration and gangrene when compared with nondiabetics. Nondiabetics typically presented with rest pain. The outcome of foot salvage surgery was evaluated by postoperative ankle-branchial indices as well as limb salvage rates. Ankle-brachial indices increased significantly in both groups. Fifty-five percent of the diabetics and 67 percent of the nondiabetics had a postoperative ankle-brachial index of 0.8 or greater. Overall foot salvage at 1 year was 84 percent. Foot salvage in patients with diabetes was 78 percent compared with 86 percent in nondiabetics. In this subset of patients with threatened limb loss confirmed by hemodynamic measurements, the results of vascular reconstruction were comparable in both diabetic and nondiabetic patients.

Laser thermal angioplasty for the treatment of obstruction of the distal superficial femoral or popliteal arteries.

The success rates and clinical effectiveness of percutaneous laser thermal angioplasty for obstruction of the distal superficial femoral or popliteal arteries were assessed. Laser thermal angioplasty was performed with the first commercially available laser system on 25 atherosclerotic vascular lesions in 20 lower extremities of 18 patients. Fifteen of the lesions were occlusions (average length, 5.6 +/- 3.1 cm), and 10 were high-grade stenoses (average length, 2.6 +/- 1.8 cm). Indication for angioplasty was claudication limiting life-style in 12 extremities and threatened limb loss in eight. All patients were treated with a 1.5- or 2.0-mm metal-capped optical fiber attached to a 14-W argon-ion laser. Balloon angioplasty was performed after laser recanalization in all successful cases. The patients were followed by Doppler ankle/brachial index and clinical evaluation. Laser thermal angioplasty was technically successful (vessel recanalization) in 18 (90%) of 20 of the cases. Fourteen (70%) of 20 extremities were successes by ankle/brachial index follow-up, while 15 (75%) of 20 remained clinically improved after an average follow-up of 7.8 +/- 5.3 months. Laser thermal angioplasty has a technical and clinical success rate that compares favorably with previous reports of balloon angioplasty. With proper patient selection, laser thermal angioplasty can reduce the difficulty of traversing lesions that are amenable to standard balloon angioplasty and increase the number of vascular lesions that can be treated percutaneously but could not be recanalized without the use of laser energy.

Factors affecting the outcome of 463 femorotibial reconstructions.

Between 1973 and 1986, 463 infrapopliteal bypasses were performed on 408 limbs in 383 patients at Royal Prince Alfred Hospital. There were 265 males and 118 females. Their mean age was 69 years, 30% were diabetic, 71% smoked and 38% were hypertensive. The indication for surgery was threatened limb loss in 350 limbs and short distance claudication in 58 limbs. The peri-operative mortality rate was 5%. Cumulative graft patency was 58% (s.e.m. = 2.7) at 5 years. The limb salvage rate was 66% (s.e.m. = 2.5) at 5 years. Cumulative patency rate for autogenous grafts (n = 332) was 63% (s.e.m. = 3.2) at 5 years compared with the cumulative patency rate for synthetic grafts (n = 131) of only 38% (s.e.m. = 5) at 5 years (P less than 0.05). There was no significant difference between the cumulative patency of autogenous grafts originating from the common femoral artery (n = 195) and those from the superficial femoral artery (n = 111). Cumulative patency of autogenous grafts did not significantly differ with the site of distal anastomosis; posterior tibial (n = 79), anterior tibial (n = 98), peroneal artery (n = 138) with 5-year cumulative patency rates of 65% (s.e.m. = 6.4), 65% (s.e.m. = 6.1) and 70% (s.e.m. = 4.6) respectively (P greater than 0.05). Autogenous graft material is the most important determinant of a durable result from femorotibial bypass. Proximal and distal anastomotic sites should be chosen to allow maximal utilization of available autogenous vein.

Improved patency in reversed femoral-infrapopliteal autogenous vein grafts by early detection and treatment of the failing graft.

One hundred two femoral-infrapopliteal bypasses, in which reversed autogenous saphenous vein grafts were used, were performed from January 1978 to July 1984, in 94 patients with severe claudication (14%) or threatened limb loss (86%). Follow-up examinations at 3-month intervals during the first 18 months and at 6-month intervals thereafter were performed to document the return of ischemic symptoms or loss of peripheral pulses. Ankle pressure index and pulse volume recordings were also measured. A decrease in ankle pressure index equal to or greater than 0.2 or a pulse volume recording decrease of 5 mm or more with or without confirmatory symptoms were indications for repeat arteriography. Twenty-two primary graft or anastomotic stenoses were discovered in 19 grafts during follow-up. Seventy-eight percent of these lesions were treated primarily by percutaneous transluminal angioplasty and the remainder were treated by short proximal interposition grafts or patch graft angioplasty. Twenty-five grafts occluded during follow-up and all of these were considered to have failed for purpose of life-table analysis. Stenotic lesions, which were corrected before occlusion, were listed as continuously patent under secondary patency and as failed under primary patency life-table analysis. The secondary graft patency rate was 70% at 5 years, which was significantly higher (p less than 0.01) than the primary patency rate (47%), which was obtained without intervention. This 23% differential represents graft salvage achieved by careful surveillance and is reflected not only by improved patency but also by high limb salvage rates (86%) observed at 5 years.

Improved patency in reversed femoral-infrapopliteal autogenous vein grafts by early detection and treatment of the failing graft

One hundred two femoral-infrapopliteal bypasses, in which reversed autogenous saphenous vein grafts were used, were performed from January 1978 to July 1984, in 94 patients with severe claudication (14%) or threatened limb loss (86%). Follow-up examinations at 3-month intervals during the first 18 months and at 6-month intervals thereafter were performed to document the return of ischemic symptoms or loss of peripheral pulses. Ankle pressure index and pulse volume recordings were also measured. A decrease in ankle pressure index equal to or greater than 0.2 or a pulse volume recording decrease of 5 mm or more with or without confirmatory symptoms were indications for repeat arteriography. Twenty-two primary graft or anastomotic stenoses were discovered in 19 grafts during follow-up. Seventy-eight percent of these lesions were treated primarily by percutaneous transluminal angioplasty and the remainder were treated by short proximal interposition grafts or patch graft angioplasty. Twenty-five grafts occluded during follow-up and all of these were considered to have failed for purpose of life-table analysis. Stenotic lesions, which were corrected before occlusion, were listed as continuously patent under secondary patency and as failed under primary patency life-table analysis. The secondary graft patency rate was 70% at 5 years, which was significantly higher (p < 0.01) than the primary patency rate (47%), which was obtained without intervention. This 23% differential represents graft salvage achieved by careful surveillance and is reflected not only by improved patency but also by high limb salvage rates (86%) observed at 5 years.

Lessons learned in adopting the in situ saphenous vein bypass

A 3-year experience with in situ saphenous vein bypasses was analyzed to evaluate the suitability of the conduit, the effect on vein utilization rate, the ease of valve ablation, the incidence of persistent arteriovenous (AV) fistula, the duration of the operation, and the nature of the learning curve to become adept at this technique. From 1981 through 1983, 74 patients underwent 55 femoral-tibial and 23 femoral-popliteal in situ saphenous vein bypasses. The operative indications were threatened limb loss in 76 (97%) and disabling claudication in 2 (3%); 35 of 74 patients (48%) were diabetic. In the last year pulsed Doppler spectrum analysis was added to arteriography for intraoperative graft assessment. For 55 femoral-tibial grafts measured by life-table patency rates at 30 days, only one femoral-popliteal graft failed (112 years). Complete vein utilization was accomplished in 91% of the bypasses attempted. In 41 of the 78 (51%) grafts, vein diameter was 3.5 mm or less. Operative time decreased with experience. Pulsed Doppler spectral analysis has proved useful for intraoperative graft evaluation. The in situ saphenous vein has become the conduit of choice for infrageniculate bypass.

Arteriovenous fistula in arterial reconstruction of the ischemic limb.

The high flow associated with an arteriovenous fistula has been shown to help maintain patency in small arterial anastomoses. In 37 male patients we created common ostium arteriovenous fistula at the distal tibial or peroneal anastomosis as a part of their arterial reconstruction for threatened limb loss. Limb salvage was achieved in 28. Successful amputations at a lower level than would have been anticipated were performed in three. There was early graft failure in four patients resulting in below-the-knee amputations. This operative approach may be helpful in patients who have had previous revascularization procedures that have failed, who resist the idea of amputation, and who fulfill the angiographic criteria of extremely poor runoff with an absent or deficient pedal arch.

Femoropopliteal tibial bypass: What price failure?

The consequences of failure in 235 femoropopliteal and femorotibial operations are reviewed and compared with the benefits of success so that an accurate perspective of risk-benefit analysis can be achieved. In 72 operations performed for claudication, 10 grafts thrombosed early. The cost included nine reoperations to achieve eight patent grafts and a 12 day average increase in hospital stay. There were no deaths. The benefit obtained was 70 of 72 (97 percent) asymptomatic limbs. In 163 grafts placed for limb salvage, there were 58 initial thromboses. Reoperation in 28 produced an additional 14 patent grafts. The cost of thrombosis was an increase in mortality from 5.6 to 10.7 percent, a 12 day average increase in hospital stay, and raising of preoperative predicted amputation level from below to above the knee in 11 patients with thrombosed grafts whose distal anastomoses were below the knee. This contrasted with a 73 percent limb salvage rate in 104 patients whose preoperative predicted amputation level was below the knee, and a 54 percent limb salvage rate and a 12 percent lowering of amputation level in 39 patients whose preoperative amputation level was above the knee. Of patients with patent grafts, 89 percent achieved limb salvage. We conclude that the benefits of success in attempted vascular reconstruction for threatened limb loss far outweigh the risks of failure and that the combined results were far superior to the expected outcome in comparable patients undergoing primary amputation.

Use of isovolemic hemodilution in the management of arterial ischemia in patients with polycythemia

The management of patients with both polycythemia and limb-threatening ischemia presents many difficulties because in this population, vascular surgical procedures carry a particularly high incidence of hemorrhagic and thromboembolic complications. We evaluated the use of acute isovolemic hemodilution in 12 polycythemic patients who required urgent surgery due to severe ischemia and threatened limb loss. Within 48 hours, blood was withdrawn in units of 500 ml and simultaneously replaced with 1,500 ml of lactated Ringer's solution until a hematocrit of 35 to 40 percent was achieved. After hemodilution, two patients had such a marked improvement that no further therapeutic measures were required immediately. Four patients showed definite improvement in pulmonary vascular resistance tracings and segmental Doppler pressures, but ischemia was not fully ameliorated. These patients together with the remaining six patients underwent vascular surgery within 1 to 14 days after hemodilution. A hematocrit of 32 to 40 percent was maintained during the perioperative period. All arterial reconstructions were successfully completed and there were no perioperative failures. No pulmonary emboli, myocardial infarctions, or deaths occurred in this period. These results indicate that in polycythemic patients, urgent vascular surgery can be performed more safely with the concomitant use of acute isovolemic hemodilution.

Femorotibial bypass grafts with sequential technique. Clinical results.

Twenty-three patients (mean age, 71 years) have undergone femorotibial bypass grafting with a sequential side-to-side popliteal anastomosis since 1975, 96% because of threatened limb loss. Twenty-one grafts were of autogenous saphenous vein and two were composites of prosthesis and vein. Ankle-brachial indices increased from 0.40 +/- 0.27 to 0.84 +/- 0.36. Intraoperative flow measurements showed a 40% to 75% augmentation in flow with the sequential anastomosis. Patients who required amputation in the early postoperative period because of graft failure failed to show improvement in ankle indices and did not manifest healing of their ischemic ulcerations. Nineteen of 23 limbs (83%) were salvaged by operation. Follow-up ranged from two to 50 months (mean, 23 months). Graft patency calculated by the life-table method was 74% at one year, 68% at two years, and 62% at four years.

Limb ischemia during intra-aortic balloon pumping: Indication for femorofemoral crossover graft

Catheter insertion for intra-aortic balloon pumping (IABP) was successful in 91% of 332 candidates. Fifty-three patients (16.5%) had significant catheter-associated vascular complications, of which lower extremity ischemia with threatened limb loss was the most prevalent (70%). Thirty-six of these patients required an angioplastic repair or vascular grafting. Of the 36, 19 patients with ischemia who needed continued balloon support received femorofemoral (F-F) grafts to restore and maintain adequate limb perfusion. Wound infection occurred in six of the patients but there was no limb loss. F-F grafting is a simple procedure that requires little time and allows one to maintain IABP for prolonged periods without concern for critical obstruction to limb perfusion.